34 min listen
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
ratings:
Length:
54 minutes
Released:
Aug 21, 2023
Format:
Podcast episode
Description
Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both of small-but-mighty Rezolute Bio's candidates onto the next phases of their journey. This year, on the back of a $130 million investment, Rezolute Bio is prepping its RZ358 candidate, a monoclonal antibody for congenital hyperinsulinism, for a pivotal phase 3 trial. On this week's epsiode of the Business of Biotech, we're settling in for an interrogation of Elam on the management principles of maintaining multi-candidate clinical momentum among highly disparate candidates and raising big dollars as a small biotech. Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!
Released:
Aug 21, 2023
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration by Business Of Biotech